Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Delhi HC directs...

    Delhi HC directs cashless service to all hospitals: GIPSA stayed on Ophthalmological Society petition

    Farhat NasimWritten by Farhat Nasim Published On 2019-06-13T15:23:14+05:30  |  Updated On 14 Aug 2021 11:44 AM IST

    New Delhi: Breaking the alleged cartel of public sector general insurance companies when it comes to mediclaim treatment, the Delhi High court has recently ruled that insurance companies would have to honour cashless mediclaim(s) for policyholders who are treated at any healthcare establishments registered with Government.


    This major relief for patients after the court's decision comes in wake of a campaigning lead by Delhi Ophthalmological Society together with All India Ophthalmological Society.


    Putting an end to a system where the companies and TPAs insisted that a hospital had to be registered with them, the court in its interim order ruled that insurance companies will give empanelment to all healthcare providers duly registered with respective state authorities for cashless facility.


    Further, as updated by the representative, the court held, "the terms and conditions of the insurance policy to be followed for the patients to get the benefits as per the terms and conditions of their policies and the duly registered healthcare providers, even if their name is not on the list for cashless facility, can avail the same on all India basis."


    Also Read: Medical Insurance to refund MRI, pre-operation expenses under mediclaim : Consumer Panel


    The move dents the functioning of General Insurance Public Sector Association (GIPSA), group of public sector insurance companies formed in 2011 which till now was only honouring cashless claims with empanelled hospitals.


    However, this was objected to by the association of ophthalmologists in Delhi High court who alleged GIPSA of acting like a CARTEL and failing to observe transparency in the empanelment process.


    Speaking to Medical Dialogues, Dr Chander Prakash Khandelwal, Member, TPA SubCommittee, Delhi Ophthalmological Society called GIPSA an alleged cartel and being corrupt, non-transparent and arbitrary in its working by using all available avenues.


    " I filed complaints with IRDA, concerned officer & even PMO. I even used Tweeter but of no avail," said Dr Khandelwal.


    With the rising issue, the association approached these public sector general insurance companies, that were constituents of, however, the companies did not acknowledge the concern. Subsequently, the body sought legal remedies under the Chairmanship of Dr Rajinder Khanna, supported by Dr Subhash Dadeya and others, thereby, filing a PIL in the Delhi High Court, he informed.


    Dr Seema Singhal, advocate Delhi Ophthalmological Society, contended that the General Insurance Public Sector Association (GIPSA), a group of public sector insurance companies formed in 2011 has failed to observe transparency in the empanelment process.


    Moreover, negligible empanelment has been entertained in Delhi while the agents or third-party administrators (TPAs) demands an extraordinary amount of money for empanelment.


    Dr Khandelwal further alleged that GIPSA is not a legal entity but a group of insurance companies unnoticed by Insurance Regulatory and Development Authority (IRDA).


    "We filed RTIs asking IRDA regarding GIPSA and its legality. However, IRDA regulator mentioned that they have no information about the same," said Dr Khandelwal.


    The order, an interim ruling, was passed by a bench of then, Chief Justice Rajendra Menon and Justice Brijesh Sethi on May 31.


    Though the current order was limited to patients seeking eye treatment, the court found fault with the very basis of GIPSA's guidelines and the external system of "network hospitals" to exclude government-registered hospitals. It may, therefore, be applied to other treatments as well, reports TOI.


    Also Read: Form panel to disburse medical claim under CGHS: SC to Centre

    All India Opthalmological Societybest insurance policycartelcashless mediclaimsDelhiDelhi high courtDelhi Opthalmological Societyempanelmentempanelment processGIPSAHealthcareHigh Courtinsuranceinsurance policyIRDAJustice Brijesh SethiJustice Rajendra MenonmedicalMedical ClaimmediclaimOpthalmological SocietyopthalmologistsState Government
    Source : with inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok